Digital healthcare solutions provider MC10 has entered a research collaboration with US-based rehabilitation research hospital Shirley Ryan AbilityLab to develop new treatments for neurodegenerative disease and motion disability.

The collaboration will see Shirley Ryan AbilityLab perform clinical research studies of MC10’s wearable sensor system BioStampRC to determine its use in clinical and home settings for enhanced rehabilitation process.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

BioStampRC is developed to capture physiological data from across the body and features a flexible technology called BioStamp Sensor that easily adapts to the human body.

“We look forward to developing new therapies and solutions with BioStampRC sensors, furthering our goal of improving treatment and recovery, and of advancing human ability.”

The sensor can also be used during activities such as exercise and sleep and can be integrated into the researcher workflow using mobile and web applications.

Shirley Ryan AbilityLab innovation and clinical research executive director David Zembower said: “MC10’s technology has the potential to reshape rehabilitation.

“We look forward to developing new therapies and solutions with BioStampRC sensors, furthering our goal of improving treatment and recovery, and of advancing human ability.”

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

The companies intend to work towards addressing unmet clinical and therapeutic needs in the field of physical medicine and rehabilitation.

They will initially target different neurodegenerative diseases, injuries that cause motion/biomechanics-related disabilities such as stroke, traumatic brain injury and incomplete spinal cord injury.

MC10 CEO Scott Pomerantz said: “By collaborating with the Shirley Ryan AbilityLab, an institution committed to driving breakthroughs in human ability, we’re positioning our technology to make a real, positive impact on human health.”

The firm combines its ultra-thin, flexible body-worn sensors with advanced analytics for obtaining better health insights through physiological data.

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact